OTCWagon, ONCE AGAIN, Initiates Coverage on, Undervalued - Therma Bright, Inc. (TSX:V:THRM)

TORONTO - Aug. 5, 2021 - PRLog -- Therma Bright, Inc. (TSX:V:THRM) the developer of the AcuVid COVID-19 rapid antigen saliva test, is a progressive medical diagnostic and device technology company focused on providing consumers and medical professionals with quality, innovative solutions that address some of today's most important medical and health care challenges.

The company's initial breakthrough proprietary technology delivers effective, non-invasive and pain-free skin care. Therma Bright received a Class II medical device status from the U.S. Food and Drug Administration for its platform technology, which is indicated for the relief of the pain, itch and inflammation of a variety of insect bites or stings.

Therma Bright, Inc. (TSX:V:THRM) has come so far in the past year. While the majority of companies were scrambling to keep their companies afloat, Therma Bright, Inc. (TSX:V:THRM) was prepared and thriving.

OTCWagon is extremely pleased to be bringing a AAAA+ company to our investors. NOW is the time to get in on THRM!